MetaCap

Werewolf Therapeutics (HOWL) vs Quantum Cyber N.V. (QUCY)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Werewolf Therapeutics (HOWL) has outperformed Quantum Cyber N.V. (QUCY) over the past year, gaining 8.4% versus a loss of 48.7%. Over five years, HOWL leads with a -93.7% price change compared with -94.8% for QUCY. Werewolf Therapeutics is the larger company by market cap ($46.0 million vs $44.7 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

HOWL+8.43%QUCY-48.75%
+273%+94%-84%
Nov 21, 20251 yearNov 20, 2026
HOWL-94.08%QUCY-94.78%
+197%+43%-112%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

HOWL versus QUCY key metrics
MetricHOWLQUCY
Share price$0.9466$0.512
Market cap$46.00M$44.67M
1-day change-3.97%-7.25%
YTD return+49.31%-54.29%
1-year return+8.43%-48.75%
5-year return-93.68%-94.80%
EPS (TTM)$-0.58$-2.27
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$537.08K
Revenue growth (YoY)—-39.92%
Net income (latest FY)$-60.82M$-16.21M
Gross margin—72.58%
Operating margin—-3004.97%
Net margin—-3018.31%
52-week high$1.20$4.93
52-week low$0.27$0.30
Distance from 52-week high-21.12%-89.61%
Analyst consensusnonenone
Avg. price target upside+639.49%+1657.81%
Average volume1.08M528.02K
Shares outstanding48.60M87.24M
Employees3910
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • HOWL has outperformed QUCY by 57.2 percentage points over the past year.

About Werewolf Therapeutics

HOWL stock →

Werewolf Therapeutics, Inc., a biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. The company designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies through its proprietary PREDATOR platform.

Health Care · Biotechnology: Pharmaceutical Preparations · 39 employees

About Quantum Cyber N.V.

QUCY stock →

Quantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions.

Health Care · Biotechnology: Pharmaceutical Preparations · 10 employees

HOWL vs QUCY FAQ

Which is bigger, Werewolf Therapeutics or Quantum Cyber N.V.?

Werewolf Therapeutics (HOWL) is larger, with a market capitalization of $46.00M compared with $44.67M for Quantum Cyber N.V. (QUCY).

Which stock has performed better over the past year, HOWL or QUCY?

HOWL returned +8.43% over the past 12 months, compared with -48.75% for QUCY (price return, excluding dividends). Past performance does not predict future results.

Are Werewolf Therapeutics and Quantum Cyber N.V. in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons